Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

[Analysis of first-line chemoresistance and prediction of chemo-response in non-small cell lung cancer by comparative genomic hybridization].

Hu Y, Gao YN, Feng FY, Lin DM, Jiao SC.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2010 Aug;32(4):389-93. doi: 10.3881/j.issn.1000-503X.2010.04.006. Chinese.

2.

Molecular cytogenetic analysis of non-small cell lung carcinoma by spectral karyotyping and comparative genomic hybridization.

Luk C, Tsao MS, Bayani J, Shepherd F, Squire JA.

Cancer Genet Cytogenet. 2001 Mar;125(2):87-99.

PMID:
11369051
3.

Genomic-wide cDNA microarray screening to correlate gene expression profile with chemoresistance in patients with advanced lung cancer.

Oshita F, Ikehara M, Sekiyama A, Hamanaka N, Saito H, Yamada K, Noda K, Kameda Y, Miyagi Y.

J Exp Ther Oncol. 2004 Jul;4(2):155-60.

PMID:
15500010
4.

Comparison of chromosomal imbalances in neuroendocrine and non-small-cell lung carcinomas.

Michelland S, Gazzeri S, Brambilla E, Robert-Nicoud M.

Cancer Genet Cytogenet. 1999 Oct 1;114(1):22-30.

PMID:
10526531
5.

Genetic aberrations in prostate carcinoma detected by comparative genomic hybridization and microsatellite analysis: association with progression and angiogenesis.

Strohmeyer DM, Berger AP, Moore DH 2nd, Bartsch G, Klocker H, Carroll PR, Loening SA, Jensen RH.

Prostate. 2004 Apr 1;59(1):43-58.

PMID:
14991865
6.

Gain at chromosomal region 5p15.33, containing TERT, is the most frequent genetic event in early stages of non-small cell lung cancer.

Kang JU, Koo SH, Kwon KC, Park JW, Kim JM.

Cancer Genet Cytogenet. 2008 Apr 1;182(1):1-11. doi: 10.1016/j.cancergencyto.2007.12.004.

PMID:
18328944
7.
8.

[Effect of the XRCC1 and XRCC3 genetic polymorphisms on the efficacy of platinum-based chemotherapy in patients with advanced non-small cell lung cancer].

Xu C, Wang X, Zhang Y, Li L.

Zhongguo Fei Ai Za Zhi. 2011 Dec;14(12):912-7. doi: 10.3779/j.issn.1009-3419.2011.12.03. Chinese.

9.

Molecular cytogenetic analysis of oral squamous cell carcinomas by comparative genomic hybridization, spectral karyotyping, and fluorescence in situ hybridization.

Uchida K, Oga A, Okafuji M, Mihara M, Kawauchi S, Furuya T, Chochi Y, Ueyama Y, Sasaki K.

Cancer Genet Cytogenet. 2006 Jun;167(2):109-16.

PMID:
16737909
10.

Comparative genomic hybridization analysis detected frequent overrepresentation of chromosome 3q in squamous cell carcinoma of the lung.

Chujo M, Noguchi T, Miura T, Arinaga M, Uchida Y, Tagawa Y.

Lung Cancer. 2002 Oct;38(1):23-9.

PMID:
12367789
11.

[Analyzing chromosomal abnormality in primary esophageal cancer by comparative genomic hybridization].

Wu SS, Liu JF, Wang MR.

Ai Zheng. 2007 Feb;26(2):132-6. Chinese.

PMID:
17298740
12.
13.

Genetic imbalance related to cisplatin-based chemoresistance in epithelial ovarian cancer.

Huanchun Y, Shulan Z, Jing L.

Eur J Gynaecol Oncol. 2009;30(2):181-5.

PMID:
19480250
14.
15.

p53 Gene status in relation to ex vivo chemosensitivity of non-small cell lung cancer.

Vogt U, Zaczek A, Klinke F, Granetzny A, Bielawski K, Falkiewicz B.

J Cancer Res Clin Oncol. 2002 Mar;128(3):141-7. Epub 2002 Jan 26.

PMID:
11935300
16.
17.

Genomic profiles associated with early micrometastasis in lung cancer: relevance of 4q deletion.

Wrage M, Ruosaari S, Eijk PP, Kaifi JT, Hollmén J, Yekebas EF, Izbicki JR, Brakenhoff RH, Streichert T, Riethdorf S, Glatzel M, Ylstra B, Pantel K, Wikman H.

Clin Cancer Res. 2009 Mar 1;15(5):1566-74. doi: 10.1158/1078-0432.CCR-08-2188. Epub 2009 Feb 10.

18.

Chromosome 3 imbalances are the most frequent aberration found in non-small cell lung carcinoma.

Lu YJ, Dong XY, Shipley J, Zhang RG, Cheng SJ.

Lung Cancer. 1999 Jan;23(1):61-6.

PMID:
10100147
19.
20.

Association between polymorphisms of ERCC1 and XPD and clinical response to platinum-based chemotherapy in advanced non-small cell lung cancer.

Li F, Sun X, Sun N, Qin S, Cheng H, Feng J, Chen B, Cheng L, Lu Z, Ji J, Zhou Y.

Am J Clin Oncol. 2010 Oct;33(5):489-94. doi: 10.1097/COC.0b013e3181b9cedc.

PMID:
20351547

Supplemental Content

Support Center